Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3047-3054

  Hamada, Katsuyuki ^a   Alemany, Ramon ^a,c   Zhang, Wei Wei ^a,c   Hittelman, Walter N ^b   Lotan, Reuben ^b   Roth, Jack A ^a,b   Mitchell, Michele Follen ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; DNA SYNTHESIS; ETIOLOGY; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WART VIRUS;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ANIMALS; APOPTOSIS; CELL DIVISION; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0029893662     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brinton, L. A. Epidemiology of cervical cancer Overview. In. N Munoz, F Bosch, K. V. Shah, and A Meheus (eds.), The Epidemiology of Human Papillomavirus and Cervical Cancer, pp 3-23 Lyon, France-IARC Science Publications, No 119, 1992
2. Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., and Enomoto, T. Allerations af the p53 gene in human primary cervical carcinoma with and without human papilloma infection Cancer Res., 52: 5323-5328, 1992.
3. Shillitoe, E. J., Kamath, P., and Chen, G. Papillomaviruses as targets for cancer gene therapy Cancer Gene Ther., 1: 193-203, 1994.
4. Seedorf, K., Krammer, G., Durst, M., Suhai, S , and Rowekamp, W. G. Identification of early proteins of the papillomaviruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J., 6: 139-144, 1987.
5. Kaur, P., McDougall, J. K., and Cone, R. Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J. Gen Virol , 70: 1261-1266, 1989.
6. Von Knebel Doeberitz, M., Oltersford, T., Schwarz, E , and Gissmann, L. Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-I cervical carcinoma cells. Cancer Res., 43: 3780-3786, 1988
7. Chen, Z , Kamath, P., Zhang, S., John, L S., Storthz, K. A., and Shillitoe, E. J. Effectiveness on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18. Cancer Gene Ther., 3: 18-23, 1996
8. Hu, G , Liu, W , Hanania, E. G., Fu, S., Wang, T , and Deisseroth, A. B. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther., 2: 19-32, 1995.
9. Heck, D. V., Yee, C. L., Howley, P M , and Monger, K. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA, 89: 4442-4446, 1992.
10. Bedell, M. A., Jones, K. H., Grossman, S. R., and Laimins, L A. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J. Virol., 63: 1247-1255, 1989.
11. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
12. Scheffner, M., Werness, B. A., Heibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
13. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M B , Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., and Cho, K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage Proc. Natl Acad. Sci. USA, 90: 3988-3992, 1993.
14. Howley, P. M., Scheffner, M. and Munger, K. Oncoproteins encoded by the cancer-associated human papillomavirus target the products of the retinoblastoma and p53 tumor suppressor genes. Cold Spring Harbor Symp. Quant. Biol , 56: 149-155, 1991.
15. Zhang, W W., Fang, X F., Mazur, W., French, B. A., Georges, R. N., and Roth, J A. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther., 1: 4-15, 1994.
16. Liu, T. J , Zhang, W W , Taylor, D. T., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene with a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
17. Yee, C , Krishnan-Hewlett, I., Baker, C., C., Schlegel, R., and Howley, P. M Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol., 119 361-356, 1985.
18. Graham, F. L., and Prevec, L. Manipulation of adenovirus vectors. In: E J. Murray (ed.), Methods in Molecular Biology, Gene Transfer and Expression Protocols, pp. 109-128. New Jersey: The Humana Press, Inc., 1991.
19. Gavrieli, Y , Sherman, Y , and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
20. Diller, L., Kassel, J , Nelson, C E , Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
21. Fujwara, T , Grimm, E. A., Mukhopadhyay, T., Cai, D W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
22. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
23. Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P , Satjipto, S., Vaillancourt, M. T., Huang, W. M., Johnson, D E., Anderson, S. C., Wen, S. F., Bookstein, R , Shepard, H. M., and Gregory, R. J Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther , 5: 1079-1088, 1994.
24. Zabner, J., Petersen, D M., Puga, A. P., Graham, S. M., Couture, L. A., Keyes, L. D , Lukason, M. J., St. George, J A., Gregory, R. J., Smith, A. E., and Welsh, M. J. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet., 6: 75-83, 1994.
25. Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA, 91: 6196-6200, 1994.
26. Kataoka, M., Kawamura, M. Nishiyama, Y , Hamada, K., Hamarnoto, K. and Matsuura, S. Patterns of failure and survival in locally advanced carcinoma of the uterine cervix treated with high dose-rate intracavitary irradiation system Int. J. Radiat. Oncol. Biol. Phys., 22: 31-35, 1992.